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Abstract
In high stakes applications such as healthcare and finance analytics, the inter-
pretability of predictive models is required and necessary for domain practitioners to
trust the predictions. Traditional machine learning models, e.g., logistic regression
(LR), are easy to interpret in nature. However, many of these models aggregate time-
series data without considering the temporal correlations and variations. Therefore,
their performance cannot match up to recurrent neural network (RNN) based mod-
els, which are nonetheless difficult to interpret. In this paper, we propose a general
framework TRACER to facilitate accurate and interpretable predictions, with a novel
model TITV devised for healthcare analytics and other high stakes applications such
as financial investment and risk management. Different from LR and other exist-
ing RNN-based models, TITV is designed to capture both the time-invariant and the
time-variant feature importance using a feature-wise transformation subnetwork and
a self-attention subnetwork, for the feature influence shared over the entire time series
and the time-related importance respectively. Healthcare analytics is adopted as a
driving use case, and we note that the proposed TRACER is also applicable to other
domains, e.g., fintech. We evaluate the accuracy of TRACER extensively in two real-
world hospital datasets, and our doctors/clinicians further validate the interpretability
of TRACER in both the patient level and the feature level. Besides, TRACER is also
validated in a high stakes financial application and a critical temperature forecasting
application. The experimental results confirm that TRACER facilitates both accurate
and interpretable analytics for high stakes applications.
1 Introduction
Database management systems (DBMS) have been extensively deployed to support OLAP-
style analytics. In modern applications, an ever-increasing number of data-driven machine
learning based analytics have been developed with the support of DBMS for complex
analysis [17, 94, 95, 50]. Particularly, there have been growing demands of machine learning
for complex high stakes applications, such as healthcare analytics, financial investment, etc.
Notably, healthcare analytics is a very important and complex application, which entails
data analytics on a selected cohort of patients for tasks such as diagnosis, prognosis, etc.
Various healthcare analytic models have been proposed for Electronic Medical Records
(EMR) that record visits of patients to the hospital with time-series medical features.
In particular, neural network (NN) based models [27, 58] have been shown to improve
the accuracy over traditional machine learning models significantly. An accurate analytic
model can help healthcare practitioners to make effective and responsive decisions on
patient management and resource allocation.
A version of this preprint will appear in ACM SIGMOD 2020.
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However, accuracy alone is far from satisfactory for healthcare analytics and other high
stakes applications in deployment. In this paper, we shall use healthcare analytics as our
driving use case. Suppose an accurate model has been trained and deployed for in-hospital
mortality prediction. Simply reporting to the doctors that “for this patient, the probability
of mortality estimated by the model is 26%” is unacceptable since in life-and-death medical
decisions, a single number without proper explanations is meaningless for doctors to take
interventions. To alleviate this issue, it is essential to devise an interpretable model,
explaining “why” certain decisions are made [67], e.g., why a 26% probability of mortality is
produced for a specific patient. Such an interpretable model is critical to provide medically
meaningful results to the doctors and insightful advice to the practitioners of other high
stakes applications as well.
Recently, various approaches have been proposed to explain the prediction results of neural
network models [47], some of which particularly focus on healthcare analytics [61, 29, 81].
For example, attention modeling has been adopted to compute the visit importance, i.e.,
the importance of each visit of a patient [61] on the final prediction. Nonetheless, the visit
importance only represents which visit is important and thus is not adequate to explain
how and why the prediction is generated from the “important” visits. Typically, doctors
consider one visit to be more important when certain important indicators, i.e., medical
features, of that visit deviate far from a normal range. Therefore, the feature importance
is more informative than the visit importance, and can be exploited to interpret model
predictions.
However, the feature importance modeled in existing work is highly dependent on certain
time periods [29, 81] without differentiating the “time-invariant” and “time-variant”
feature importance. We note that the medical feature, on the one hand, has a influence
on a patient shared over the entire time series, and this is captured in the time-invariant
feature importance; on the other hand, the influence of the feature on a patient can also
vary over time periods or visits, and this is captured in the time-variant feature importance.
For instance, we examine two representative laboratory tests, i.e., Glycated Hemoglobin
(HbA1c) and Blood Urea Nitrogen (Urea), to predict the risk of patients developing acute
kidney injury (AKI). We first train one single logistic regression (LR) model by aggre-
gating each medical feature across all the seven-day data (see the NUH-AKI dataset in
Section 5.1.1). The weight coefficient thus denotes the time-invariant feature importance,
which reflects the influence of the corresponding feature on the final prediction. We also
train seven LR models independently for the data of each day. The learned coefficients of
each day are regarded as the time-variant feature importance. As shown in Figure 11, we
can see that HbA1c and Urea have different time-invariant feature importances which has
been confirmed by doctors that Urea is more important in diagnosing kidney diseases [3].
Specifically, the time-variant feature importance increases over days in Urea while it fluc-
tuates in HbA1c. The explanation from our doctors is that Urea is a key indicator of
kidney dysfunction, so its importance grows approaching the AKI prediction time. The
same phenomenon can be found in Estimated Glomerular Filtration Rate (eGFR) [4],
which serves as a measure of assessing kidney function. In contrast, HbA1c [5] is typically
used to assess the risk of developing diabetes; hence, it has relatively low time-invariant
feature importance and stable time-variant feature importance in the prediction.
To produce meaningful interpretation in healthcare analytics and other high stakes appli-
1In each LR model (either time-invariant or time-variant), after training the model and obtaining the
coefficients, we normalize the coefficients of all features via a Softmax function for illustration.
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Figure 1: The normalized coefficients in both an LR model trained on the aggregated
seven-day data (leftmost) and seven LR models trained separately. We illustrate with two
representative laboratory tests HbA1c and Urea (best viewed in color).
cations, we propose a general framework TRACER to provide accurate and inTerpRetAble
Clinical dEcision suppoRt to doctors and practitioners of other domains. Specifically, we
devise a novel model TITV for TRACER, which captures both Time-Invariant and Time-
Variant feature importance for each sample (e.g., each patient in healthcare analytics)
in two different subnetworks, with the former shared across time and the latter varying
across different time periods. We adopt the feature-wise transformation mechanism, which
is known as feature-wise linear modulation (FiLM) [32, 72, 46] in one subnetwork to model
the time-invariant feature importance. While for the time-variant feature importance, we
adopt a self-attention mechanism in the other subnetwork to model the fine-grained infor-
mation. Trained with these two subnetworks of TITV jointly in an end-to-end manner,
TRACER can produce accurate predictions and meanwhile, meaningful explanations in
analytics for high stakes applications.
The main contributions can be summarized as follows:
• We identify the research gaps in modeling the feature importance, where existing meth-
ods are overly dependent on certain time periods without differentiating the time-
invariant and the time-variant feature importance. Contrarily, we demonstrate that
both time-invariant and time-variant feature importance are essential for high stakes
applications such as healthcare analytics.
• We propose a general framework TRACER to provide both accurate and interpretable
decision support to doctors in healthcare analytics, and practitioners in other high
stakes applications. Specifically, in TRACER, we devise a novel model TITV that takes
into consideration the time-invariant feature importance via the FiLM mechanism and
the time-variant feature importance via the self-attention mechanism.
• We evaluate the effectiveness of TRACER for healthcare analytics in two real-world hos-
pital datasets. Experimental results confirm that TRACER can produce more accurate
prediction results than state-of-the-art baselines. Meanwhile, both patient-level and
feature-level interpretation results based on the feature importance of TRACER have
been validated by doctors to be medically meaningful, which shows that TRACER can
assist doctors in clinical decision making.
• We illustrate that TRACER is also applicable to other high stakes applications. Specifi-
cally, TRACER is further validated in a financial investment application and a tempera-
ture forecasting application.
Our proposed TRACER is integrated into GEMINI [57], an end-to-end healthcare data an-
alytics system, to facilitate the accuracy and interpretability of healthcare analytics. The
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remainder of this paper is organized as follows. In Section 2, we review the related work.
In Section 3, we introduce our general framework TRACER in the context of healthcare
analytics. In Section 4, we elaborate the detailed design of the core component of TRACER,
the TITV model. In Section 5, we analyze the experimental results of TRACER in health-
care analytics, which demonstrate its effectiveness in terms of both prediction accuracy
and interpretation capability. To illustrate that TRACER is also applicable to other high
stakes applications, we conduct experiments on a financial application and a temperature
forecasting application in this section. We conclude in Section 6.
2 Related Work
2.1 Healthcare Analytics
Healthcare analytics is to conduct analytic tasks on patient data, which typically include
diagnosis, prognosis, etc. Due to the recent advancements of DBMS [84, 76], researchers
manage to achieve more optimized support for healthcare analytics in terms of both ef-
fectiveness and efficiency [22]. Through high-quality healthcare analytics, we can provide
medical professionals with useful insights on both diseases and patients, hence contributing
to better patient management and faster medical research advancement.
In recent years, EMR data collected from various hospitals and health organizations, be-
comes one of the major data sources for healthcare analytics. EMR data is heterogeneous
in nature, consisting of information that ranges from patients’ social and demographic in-
formation, to structured medical features such as diagnoses, laboratory tests, and further
to unstructured data such as magnetic resonance images and doctors’ notes. The struc-
tured data can be fed into TRACER directly, and the unstructured data can be converted
into structured features before being input to TRACER for analytics.
The typical EMR data analytics pipeline from EMR Data Acquisition to Interpretation/Vi-
sualization is illustrated in Figure 2, where each module plays a critical role. To begin
with, we collect raw EMR data, which may be quite “dirty” and thus may not be suit-
able for analytics directly. Therefore, we need to feed the raw EMR data into the EMR
Data Integration and EMR Data Cleaning module to improve the data quality. Then the
clean EMR data goes through the EMR Analytic Modeling module for analytics and the
analytic results are interpreted and visualized to render the derived medical insights easy
to comprehend for medical experts, researchers, patients, etc. Finally, we make use of
doctors’ validation and feedback given based on the interpretation or visualization results
to improve the whole EMR data analytics pipeline. This EMR data analytics pipeline is
supported by GEMINI [57], a generalizable medical information analysis and integration
platform, with the objective to design and implement an integrative healthcare analytic
system in order to address various kinds of healthcare problems. GEMINI supports differ-
ent key functionalities, such as capturing the feature-level irregularity in EMR data [97],
resolving the bias in EMR data [96] and an adaptive regularization method [60]. Our pro-
posed TRACER is integrated into GEMINI to facilitate the accuracy and interpretability
of healthcare analytics.
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Figure 2: EMR data analytics pipeline.
2.2 Interpretability
Interpretability, measuring the degree that the cause of a decision can be understood by
human [15, 64], has drawn great attention in recent years. When designing analytic models,
we are faced with a trade-off between what is predicted (e.g., if a hospitalized patient will
develop AKI in two days and what is the corresponding probability) and why a decision
is made (e.g., which features indicate this patient’s future development of AKI) [67]. The
latter one which answers the why question lays emphasis on interpretability. In some high
stakes applications with high complexity and demanding requirements, it is not adequate
to only know the answer to the what question, because the answer to the why question
can improve the understanding of human on the problem, make human aware of when the
model succeeds/fails, and boost the trust of human on the analytic results. Hence, it is
vitally essential to take interpretability into consideration when designing analytic models.
2.3 Interpretability in Healthcare
There exist some traditional machine learning methods which can achieve high inter-
pretability [44, 83, 100, 98]; however, due to not considering the longitudinal property of
EMR data, their performance may be degraded.
Deep learning [54] has recently aroused wide interest due to its ability to achieve state-of-
the-art performance in a large number of applications [48, 77, 63]. In deep learning, there
is a category of models, i.e., recurrent neural networks (RNN), such as the long short-term
memory (LSTM) model [37] and the gated recurrent unit (GRU) model [26], proposed to
capture the dynamic behavior in sequential data. Although effective in modeling time-
series data, the lack of interpretability tends to become an obstacle for deploying RNN-
based models in healthcare analytics, despite some existing attempts [41, 24]. Fortunately,
attention mechanism [12] comes into being, with which we can visualize the attention
weights to facilitate the interpretability of healthcare analytics.
Some researchers have applied the attention mechanism in healthcare analytics [28, 13];
nonetheless, these studies devise attention-based approaches for incorporating domain
knowledge to improve prediction accuracy, rather than contributing to the interpretability
of analytic results.
Some other researchers employ the attention mechanism to facilitate interpretability.
In [61], an attention-based bidirectional RNN model is proposed to provide the inter-
pretation for each visit in diagnosis prediction, but the more fine-grained interpretation
for each medical feature is not supported. In [29], RETAIN is proposed to facilitate inter-
pretability via both visit-level attention and feature-level attention. However, these two
levels of attention are connected by multiplication and the feature-level attention already
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conveys some information of the visit-level attention. Then in [81], GRNN-HA, a model
with a hierarchical two-level attention mechanism is employed, but its two levels of at-
tention for visits and for features are not connected. Furthermore, both RETAIN and
GRNN-HA only capture the time-variant feature importance which is heavily dependent
on a certain visit, instead of a patient’s whole time series.
Different from existing work, we highlight the necessity of capturing both the time-
invariant and the time-variant feature importance in healthcare analytics at the same
time. In our proposed framework TRACER, specifically, in the TITV model, we combine
the time-invariant feature importance via a FiLM mechanism and the time-variant feature
importance via a self-attention mechanism to achieve this goal.
3 TRACER Framework
We propose a general framework TRACER to facilitate accurate and interpretable decision
support for healthcare analytics and other high stakes applications. In this section, we
take healthcare analytics as an illuminating example to illustrate the architecture overview
of TRACER.
As shown in Figure 3, TRACER makes use of both the history time-series EMR data and
the daily generated EMR data, and then feeds these data to the core component TITV
of TRACER for analytics, in which both the time-invariant and the time-variant feature
importance are captured in modeling. Based on the analytic results, TRACER supports
doctor validation with accurate and interpretable clinical decisions in scenarios including
real-time prediction & alert, patient-level interpretation and feature-level interpretation.
Data. TRACER incorporates two data sources: (i) the history time-series EMR data
stored in the EMR database system of hospitals to obtain satisfactory performance of the
analytic models; (ii) the daily generated EMR data (e.g., the data collected from a new
patient to the hospital, or some new laboratory tests measured for a hospitalized patient)
for inference at a regular frequency, to provide real-time predictions and hence, support
more effective patient monitoring.
TITV model. The core component TITV of TRACER takes the data as input to gener-
ate predictions based on the collaboration of three modules: (1) Time-Invariant Module
computes the time-invariant feature importance representation; (ii) Time-Variant Module
computes the time-variant feature importance representation with the guidance of Time-
Invariant Module; (iii) Prediction Module takes into account the information of both
Time-Invariant Module and Time-Variant Module to generate the final predictions. The
design details and interaction of these modules will be elaborated in Section 4.
Doctor Validation. With the TITV model, TRACER facilitates doctor validation with
accurate and interpretable clinical decision support. We illustrate three representative
scenarios with the application of hospital-acquired AKI prediction as follows.
• Real-time Prediction & Alert for Daily Consultation. Suppose Doctor X is monitoring
the chance of developing AKI for a hospitalized Patient Y on a daily basis. TRACER
can help Doctor X via feeding the daily generated EMR data of Patient Y for analysis
and computing the probability of Patient Y developing AKI in two days. Once the
prediction (e.g., 85%) exceeds a predefined risk threshold (e.g., 75%), TRACER will send
an alert to notify Doctor X that Patient Y is at risk, such that Doctor X can attend
6
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Figure 3: Overview of TRACER in healthcare analytics.
to Patient Y in time to take some preventive treatments to avoid deterioration. In this
scenario, TRACER assists doctors with clinical decision making and contributes to better
patient management.
• Patient-Level Interpretation for Patient-Level Analysis. Following the example above,
suppose Doctor X has suggested some treatments to Patient Y in advance and after-
ward, Doctor X decides to further investigate the EMR data of Patient Y, to find out
why he/she has an 85% probability of developing AKI. In such a scenario, TRACER
can provide interpretation analysis of Patient Y based on the history time-series EMR
data, and help identify the specific features of particular visits to the hospital that are
responsible for the prediction of developing AKI in the future. With such patient-level
interpretation, TRACER improves the understanding of doctors on each patient, and
helps identify the underlying reasons for developing certain diseases such as AKI.
• Feature-Level Interpretation for Medical Research. Suppose Doctor X has analyzed the
EMR data of a cohort of patients, who have a relatively high probability (e.g., higher
than the threshold 75%) of developing AKI, and has noticed these patients share certain
similarities in the history time-series EMR data based on the patient-level interpreta-
tion, e.g., an increasing importance of the laboratory test “C-Reactive Protein” in recent
examinations. Then Doctor X decides to further investigate the underlying pattern of
this laboratory test with regard to the AKI development in the cohort for medical re-
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search. TRACER can support the needs of Doctor X with the feature-level interpretation,
which depicts the feature importance changing pattern of this feature over time among
all patients. In this way, TRACER assists Doctor X in understanding the characteristics
of this feature in the AKI development and hence, contributes to the advancement of
medical research.
4 TITV Model
We denote a time-series sample as X = {x1, · · · ,xT } of T time windows, where the
window length is flexible, e.g., one day, one hour or one visit. Specifically, for healthcare
analytics, each time window contains the medical features of the patient extracted from
his/her EMR data, denoted as xt ∈ RD, where D is the number of medical features
and t ∈ {1, 2, · · · , T}. Each sample is extracted from a particular patient, while each
patient may have more than one sample2. Each sample also has a corresponding label
y indicating the medical status of the patient. In this section, we formulate with the
binary classification where the label is a binary value3. We note that this formulation
can be readily extended to other learning tasks such as regression by replacing the output
activation function with a linear function.
We shall elaborate on the core component of TRACER, the TITV model for analytics. We
first introduce the overall architecture of TITV and the three modules of TITV: Time-
Invariant Module, Time-Variant Module and Prediction Module. Then we analyze the
importance of each feature to the final prediction of TITV.
4.1 TITV Architecture Overview
With the input sample X = {x1, · · · ,xT }, we illustrate the generation of the prediction
yˆ from TITV in Figure 4. Specifically, TITV is composed of three modules as follows.
Time-Invariant Module. For each sample, xt is first fed into a bidirectional RNN
(BIRNN) [79] to compute a hidden representation qt. Then qt from all time windows is
averaged into a summary vector s, which flows to the FiLM generator, a unit to calculate
the scaling parameter β and the shifting parameter θ. This β calculates the time-invariant
feature importance for the sample whose influence is shared across time windows.
Time-Variant Module. We design a BIRNNFiLM(·) with β and θ from Time-Invariant
Module to conduct a feature-wise affine transformation over xt of time window t. Then we
compute the hidden representation ht withBIRNNFiLM(·), and feed it to a unit supporting
self-attention mechanism to compute the time-variant feature importance αt.
Prediction Module. We aggregate the time-invariant feature importance β and the
time-variant feature importance αt into an overall feature importance ξt. Then the final
context vector c is obtained by summarizing the product of ξt and xt for each time window
t. Finally, the context vector c is used for the prediction of label yˆ.
We note that the integration of time-invariant feature importance β and time-variant fea-
ture importance αt is non-trivial, and no previous study has investigated the integration
2The detailed extraction process will be explained in Section 5.1.1.
3In the experiments for healthcare analytics of Section 5, the binary value indicates whether a patient
will develop AKI for hospital-acquired AKI prediction or pass away for in-hospital mortality prediction.
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Figure 4: TITV with the collaboration of three modules.
of both. Specifically, β computed from Time-Invariant Module will: (i) guide the mod-
ulation of the input in Time-Variant Module for calculating αt, (ii) integrate with αt in
Prediction Module. We shall justify such integration experimentally in Section 5.2.2.
4.2 FiLM-based Time-Invariant Module
We aim to model the time-invariant feature importance shared across time, where data
in all the time windows are required and exploited. FiLM is an effective conditioning
mechanism that applies a feature-wise affine transformation on the input, and is designed
to model the feature importance [32, 72, 46]. We therefore adopt FiLM in Time-Invariant
Module for computing the time-invariant feature importance, with the input EMR data
as the self-conditioning information.
Specifically, with FiLM, we can obtain the feature-wise scaling parameter and shifting pa-
rameter for each sample. The scaling parameter represents the time-invariant importance
of the features across the entire time range of each sample. The detailed structure of
FiLM-based Time-Invariant Module is illustrated in Figure 5.
We first feed the time-series EMR data to a standard BIRNN model and obtain the hidden
representations:
(q1, · · · , qt, · · · , qT ) = BIRNN(x1, · · · ,xt, · · · ,xT ) (1)
where BIRNN(·) refers to a bidirectional GRU model, and the hidden representation
qt = [
−→qt ;←−qt ] is the concatenation of the hidden states computed from both directions (i.e.,
forward and backward). Specifically, −→qt is obtained via a forward GRU model (from x1 to
xt), and
←−qt via a backward GRU model (from xT to xt). The major advantage of BIRNN
lies in its capability to capture both the forward and the backward temporal relationship
of the EMR data, which is similar to the procedure that doctors analyze the history EMR
data of a patient from both directions. Consequently, BIRNN provides a comprehensive
representation of the time-series EMR data.
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Figure 5: Time-Invariant Module of TITV.
We further aggregate all the hidden representations of all the time windows into a summary
vector s:
s =
1
T
T∑
t=1
qt (2)
Then this aggregated representation s flows into FiLM to calculate the scaling parameter
and the shifting parameter:
β = Wβs+ bβ (3)
θ = Wθs+ bθ (4)
Note that β and θ obtained in this module will also serve as auxiliary inputs to Time-
Variant Module of TITV for better predictions, as they guide the modulation of the input
EMR data in a feature-wise manner. Further, the scaling parameter β determines the scale
of each feature and thus indicates the importance of each feature. For a given sample, β is
shared and fixed through all the time windows. β is meant to serve as the time-invariant
feature importance, which is required and thus integrated into Prediction Module.
4.3 Attention-based Time-Variant Module
We aim to differentiate the influence of different features in different time windows when
modeling the time-variant feature importance. Similar tasks have been successfully sup-
ported with the adoption of the self-attention mechanism in many areas [25, 91]. We
therefore introduce the self-attention mechanism to Time-Variant Module (as illustrated
in Figure 6) to calculate the time-variant feature importance specific to each time window.
We first feed the time-series data into an adapted BIRNN model with the auxiliary infor-
mation from Time-Invariant Module to calculate time-variant hidden representations:
(h1, · · · ,ht, · · · ,hT ) = BIRNNFiLM(x1, · · · ,xt, · · · ,xT ;β,θ) (5)
where BIRNNFiLM(·) refers to the FiLM-based bidirectional GRU model, which also takes
the scaling parameter β and the shifting parameter θ from Time-Invariant Module as
additional input.
Specifically, the detailed transformation of BIRNNFiLM(·) is given as follows, where the
revised update gate zt, reset gate rt, temporary hidden state h˜t and final hidden state ht
10
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are calculated in a bidirectional GRU model in order:
zt = σ(FiLM(Wzxt;β,θ) +Uzht−1) (6)
rt = σ(FiLM(Wrxt;β,θ) +Urht−1) (7)
h˜t = tanh(FiLM(W˜xt;β,θ) + rt  U˜ht−1) (8)
ht = (1− zt) h˜t + zt  ht−1 (9)
where σ(·) is the sigmoid(·) activation function and “” denotes the element-wise mul-
tiplication. Different from the standard bidirectional GRU model, BIRNNFiLM(·) also
exploits β and θ from Time-Invariant Module with a feature-wise affine transformation
FiLM(·) defined as:
FiLM(x;β,θ) = β  x+ θ (10)
We then employ a self-attention mechanism to compute the time-variant feature impor-
tance:
αt = tanh(Wαht + bα) (11)
where αt of the time window t will be fed into Prediction Module to attend to the features
of xt for prediction.
4.4 Prediction Module
In Prediction Module, we produce the final prediction of TITV illustrated in Figure 7.
After obtaining the scaling parameter β as the time-invariant feature importance and the
self-attention αt as the time-variant feature importance, we obtain the overall influence
in Prediction Module:
ξt = β ⊕αt (12)
where “⊕” denotes the element-wise summation. Note that β and αt are intermediate
neural network outputs which should be combined by direct summation for generally
better results [87, 36, 70]. Thereby, we integrate both the general time-invariant feature
importance β and the fine-grained time-variant feature importance αt together into the
final feature importance representation ξt.
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We then obtain the context vector c by aggregating the element-wise product of ξt and
the corresponding input xt at each time window t:
c =
T∑
t=1
ξt  xt (13)
The final predicted label of TITV is therefore:
yˆ = σ(〈w, c〉+ b) (14)
where “〈·, ·〉” denotes the inner-product of two vectors. Finally, the training of the whole
framework is achieved via the optimization of a predefined loss function L(yˆ, y) between
the prediction yˆ and the ground truth label y, e.g., the cross-entropy loss function for
binary classification:
L(yˆ, y) = −y · log(yˆ)− (1− y) · log(1− yˆ) (15)
Specifically, stochastic gradient descent back-propagation optimization can be employed to
train TITV’s model parameters Θ = {Wβ, bβ,Wθ, bθ,Wz,Uz,Wr,Ur, W˜ , U˜ ,Wα, bα,w, b}
in an end-to-end manner.
4.5 Feature Importance for Interpretation
In this subsection, we analyze the feature importance of xt,d to the predicted label yˆ, where
xt,d denotes the value of feature d at time window t of a sample X.
In binary classification, yˆ corresponds to the probability of the sample to be classified as
the positive class. Expanding Equation 14 with c (Equation 13) and ξt (Equation 12), we
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have:
yˆ = σ(〈w, c〉+ b)
= σ(〈w,
T∑
t=1
ξt  xt〉+ b)
= σ(〈w,
T∑
t=1
(β ⊕αt) xt〉+ b)
= σ(
T∑
t=1
〈w, (β ⊕αt) xt〉+ b)
(16)
Then the feature importance of xt,d to the prediction yˆ can be derived as follows:
FI(yˆ, xt,d) = (βd + αt,d) · wd (17)
where βd, αt,d and wd correspond to the d-th element of β, αt and w respectively. We
can observe that both βd and αt,d directly influence the feature importance of xt,d to yˆ.
Substitute Equation 17 into Equation 16, we have:
yˆ = σ(
T∑
t=1
D∑
d=1
FI(yˆ, xt,d) · xt,d + b) (18)
which demonstrates that all the features contribute to the final prediction of TITV with
the corresponding feature importance given by FI(yˆ, xt,d). Further, an xt,d with a positive
feature importance value indicates that xt,d positively contributes to the final prediction,
while a negative feature importance value the opposite. We note that TRACER also takes
into account the feature interactions during this process, specifically interactions of the
input features are first modeled using BIRNN in both Time-Invariant Module and Time-
Variant Module, then captured in β and αt, and finally, integrated in FI(yˆ, xt,d).
With FI(yˆ, xt,d), TRACER can provide interpretable decision support for high stakes ap-
plications. Specifically, in healthcare analytics, TRACER can help reveal the FI(yˆ, xt,d)
changing pattern of features over time for each patient to show the influence of the varying
time-series features, i.e., support patient-level interpretation analysis. Therefore, TRACER
can assist doctors to pinpoint the underlying problems of the patient. For each feature,
TRACER can help identify the FI(yˆ, xt,d) changing pattern over time on a cohort of pa-
tients, and further facilitate the understanding of the development of certain diseases for
doctors/clinicians, i.e., support feature-level interpretation analysis.
5 Experiments
5.1 Experimental Set-Up
5.1.1 Datasets and Applications
We evaluate TRACER in two real-world longitudinal EMR datasets, the NUH-AKI dataset
and the MIMIC-III dataset.
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Figure 8: AKI detection criteria: (i) absolute AKI, and (ii) relative AKI.
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Figure 9: Feature Window and Prediction Window in hospital-acquired AKI prediction.
NUH-AKI Dataset a sub-dataset extracted from all EMR data in National University
Hospital in Singapore recording more than 100,000 patients’ EMR data in 2012. In this
dataset, we target at hospital-acquired AKI prediction, i.e., to predict if a patient will
develop AKI in a hospitalized admission. As explained by medical experts, AKI disease
is defined according to the KDIGO criterion [43]. The definition of AKI is based on a
laboratory test serum creatinine (SCr) and there are two AKI detection criteria, absolute
AKI and relative AKI (as illustrated in Figure 8). Absolute AKI refers to the situation
when the SCr value increases by over 26.5umol/L within the past 48 hours, while relative
AKI refers to the case when the SCr value increases to more than 1.5 times of the lowest
SCr value within the past seven days. For each hospitalized admission of a patient, both
AKI detection criteria are checked in order to derive the label of this admission, and either
criterion can cause the AKI label to be positive.
In the NUH-AKI dataset, each hospitalized admission is used as a sample. If a sample is
positive, i.e., the patient develops AKI in this admission, we record the time when AKI
is detected, trace two days back in time as “Prediction Window” which is not used and
continue to trace seven more days back in time as “Feature Window” which is used to
construct x. Otherwise, if a sample is negative without developing AKI, then the time
recorded for the latest medical feature in this admission is used to determine the Prediction
Window and Feature Window. The relationship between Feature Window and Prediction
Window is shown in Figure 9. In hospital-acquired AKI prediction, we utilize the time-
series laboratory tests of each sample in Feature Window as input to predict if the patient
will develop AKI in this admission in two days.
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Table 1: Dataset Statistics
Dataset NUH-AKI MIMIC-III
Feature Number 709 428
Sample Number 20732 51826
Positive Sample Number 911 4280
Negative Sample Number 19821 47546
Feature Window Length 7 days 48 hours
Time Window Length 1 day 2 hours
Time Window Number 7 24
MIMIC-III Dataset [39] is a public dataset spanning from 2001 to 2012, recording
EMR data for more than 40, 000 ICU patients admitted to the critical care units. In this
MIMIC-III dataset, we conduct in-hospital mortality prediction with the time-series
laboratory tests as input. Specifically, each admission corresponds to one visit of each
patient to the hospital and for each admission, if the patient stays in the hospital for more
than 48 hours, we use it as one sample. The mortality label is derived by checking whether
the patient passes away in the hospital in this admission or not. Then the corresponding
time-series x is extracted from the laboratory tests of this admission.
We summarize some important statistics for both datasets in Table 1. Specifically, we
divide Feature Window into a number of time windows by the window length and average
the value of the same laboratory test for each time window, which is a typical way to
transform EMR data for analytics [99, 23, 58]. Then we conduct feature normalization
on the laboratory test value x to obtain the normalized value x′ as the input for analytics,
specifically x′ = (x −min)/(max −min). We note that while the laboratory tests used
in the experiments are numerical features, TRACER can readily deal with categorical or
discrete features by transforming them into numerical features via standard preprocess-
ing steps (e.g., sklearn.preprocessing.OneHotEncoder [10], pandas.get dummies [7]) before
feeding them as input.
5.1.2 Baseline Methods
We compare TRACER with LR, Gradient Boosting Decision Tree (GBDT), the stan-
dard BIRNN and several state-of-the-art methods including RETAIN [29] and variants
of Dipole [61]. The details of these baselines are as follows.
• LR takes the aggregated time-series EMR data as input for prediction. The aggregation
operation calculates the average value of the same feature across the time series.
• GBDT is an ensemble model composed of decision trees, which also takes the aggregated
time-series EMR data as input.
• BIRNN takes time-series EMR data as input and uses the BIRNN’s last hidden state
for prediction.
• RETAIN [29] is a reverse time attention model which devises a two-level attention
mechanism, i.e., visit-level attention and feature-level attention to facilitate interpretabil-
ity.
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Figure 10: Sensitivity analysis of TRACER on rnn dim and film dim in the NUH-AKI
dataset.
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Figure 11: Sensitivity analysis of TRACER on rnn dim and film dim in the MIMIC-III
dataset.
• Dipole [61] is an attention-based BIRNN model which can achieve the interpretability
for each visit through three different attention mechanisms as follows.
• Dipoleloc is Dipole with a location-based attention mechanism in which the attention
weights are computed solely based on the current hidden state.
• Dipolegen is Dipole with a general attention mechanism in which a matrix is used to
capture the relationship between every two hidden states.
• Dipolecon is Dipole with a concatenation-based attention mechanism in which the at-
tention weights are computed from the concatenation of the current hidden state and
each previous hidden state.
For the experiments, we randomly partition the samples into 80%, 10% and 10% for train-
ing, validation and test respectively. During training, for each approach (either TRACER
or baselines), the hyperparameters which can achieve the best performance in the valida-
tion data are chosen and then applied to the test data for reporting experimental results.
For both applications formalized as binary classification, we choose the area under the
ROC curve (AUC), as well as the mean cross-entropy loss (CEL) per sample as evaluation
metrics, and an accurate prediction model should have a high AUC value but a low CEL
value. Then we report the AUC value and the CEL value averaged of 10 repeats in the
test data.
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Figure 12: Experimental results of LR, GBDT, BIRNN, RETAIN, Dipoleloc, Dipolegen,
Dipolecon and TRACER.
Specifically, for TRACER, we conduct the sensitivity analysis on two critical hyperparam-
eters: (i) rnn dim, the dimension of ht in Time-Variant module; and (ii) film dim, the
dimension of qt in Time-Invariant Module. Both hyperparameters are tuned in the range
{32, 64, 128, 256, 512, 1024}. Figure 10 and Figure 11 illustrate the results of different
rnn dim and film dim settings in both datasets. Based on the results, we adopt the best-
performing hyperparameter setting rnn dim=128, film dim=512 in the NUH-AKI dataset
and rnn dim=512, film dim=64 in the MIMIC-III dataset. Other hyperparameters in-
clude the learning rate 0.001, the weight decay 5× 10−5, and the epoch number 200 with
early stopping.
5.1.3 Experimental Environment
The experiments are conducted in a server with 2 x Intel Xeon Silver 4114 (2.2GHz, 10
cores), 256G memory, 8 x GeForce RTX 2080 Ti. Models are implemented in PyTorch
1.3.1 with CUDA 10.2.
5.2 Prediction Results
5.2.1 Comparison with Baseline Methods
We report the experimental results of LR, GBDT, BIRNN, RETAIN, Dipole with three dif-
ferent attention mechanisms and our TRACER in Figure 12. In both applications, TRACER
achieves the highest AUC values and the lowest CEL values, confirming that the time-
invariant and the time-variant feature importance jointly contribute to the modeling of the
time-series EMR data and hence, both are essential to improve the prediction performance.
In both datasets, TRACER outperforms LR and GBDT significantly and the superiority of
TRACER results from the capability of utilizing time-series data for analytics.
Compared with RETAIN, TRACER can achieve a higher AUC value and a lower CEL
value with a large margin. The reason may be two-fold. First, RETAIN incorporates
time-series EMR data in the reverse time order and therefore, loses the forward time-
series information in the data. Second, in the TITV model of TRACER, the devised FiLM
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Figure 13: Experimental results of the ablation study.
mechanism which can capture the time-invariant feature importance as general guidance
to the model learning, poses a positive influence to improving the performance of TRACER.
Compared with BIRNN, TRACER illustrates better prediction performance in both datasets,
in terms of AUC and CEL. As for interpretability, TRACER can explain the prediction re-
sults via the feature importance, whereas BIRNN is hard to interpret.
Compared with Dipole, TRACER exhibits an obvious advantage over Dipole in the NUH-
AKI dataset, and also outperforms Dipole in the MIMIC-III dataset. From the perspective
of interpretability, TRACER models the feature importance, which is more informative than
the visit importance modeled by Dipole.
In summary, the proposed TRACER outperforms LR and GBDT significantly due to the
capability of modeling the time-series data and outperforms RETAIN by capturing both
time-invariant and time-variant feature importance. Further, TRACER achieves better
interpretability and meanwhile prediction performance than BIRNN and Dipole in both
datasets.
5.2.2 Ablation Study
We conduct an ablation study of the TITV model in TRACER and illustrate the experimen-
tal results in Figure 13. TRACERinv keeps Time-Invariant Module and Prediction Module
of TITV for analytics while removing Time-Variant Module to evaluate the influence of
Time-Invariant Module. Similarly, TRACERvar uses Time-Variant Module and Prediction
Module of TITV for analytics in order to demonstrate the influence of Time-Variant Mod-
ule.
According to Figure 13, we observe that Time-Invariant Module and Time-Variant Module
both contribute to boosting the performance of TRACER, as TRACERinv and TRACERvar
both achieve a lower AUC and a higher CEL than TRACER.
However, compared with Time-Invariant Module, Time-Variant Module poses a larger
influence to the performance of TRACER, as TRACERvar achieves a higher AUC value than
TRACERinv in both datasets. When considering CEL, TRACERvar outperforms TRACERinv
in the NUH-AKI dataset, and performs similarly compared with TRACERinv in the MIMIC-
III dataset. This indicates the vital influence of the time-variant feature importance in
these two applications.
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Figure 14: Experimental results of the scalability test.
5.2.3 Scalability Test
We study the scalability of TRACER by measuring the model convergence time under
different number of GPUs in both the NUH-AKI dataset and the MIMIC-III dataset. As
can be observed in Figure 14, the convergence time of the NUH-AKI dataset decreases
sub-linearly with respect to the number of GPUs used for training, due to the fact that
the controlling4 cost becomes more obvious when the processing in each GPU decreases
substantially. In contrast, when the controlling cost becomes less dominant, we can observe
that TRACER yields higher training efficiency as a whole and achieves better scalability for
the larger MIMIC-III dataset. The study confirms the scalability of TRACER that it can
be accelerated and scaled appropriately with more GPUs depending on the data size and
training requirements.
5.3 Patient-Level Interpretation
In this subsection, we report the patient-level interpretation results to demonstrate how
TRACER assists doctors to understand why a certain patient develops AKI in the hospital-
acquired AKI prediction or passes away in the in-hospital mortality prediction in the
patient-level analysis. We first adopt the best-performing checkpoint of the TITV model
in TRACER. Then for each patient, we visualize the patient-level interpretation results by
plotting the Feature Importance - Time Window distribution of the features which are
identified by doctors to be informative during the diagnosis process. Time Window is
within Feature Window, ranging from 1 day to 7 days in the NUH-AKI dataset and from
2 hours to 48 hours in the MIMIC-III dataset respectively.
5.3.1 AKI Prediction in the NUH-AKI Dataset
In the hospital-acquired AKI prediction, we show the patient-level interpretation results
of TRACER for two representative patients who developed AKI after 48 hours in Fig-
ure 15, with the features involved: “Neutrophils %” (NEUP), “Ionised CA, POCT” (ICAP),
“Sodium, POCT” (NP), “White Blood Cell” (WBC), “Carbon Dioxide” (CO2) and “Serum
Sodium” (NA).
4It includes the gradient aggregation among GPUs, the best checkpoint selection and saving, etc, which
cannot be accelerated with more GPUs.
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Figure 15: Patient-level interpretation results of TRACER in the NUH-AKI dataset.
As shown in Figure 15 (a), in Patient1’s interpretation results provided by TRACER, we
observe that NEUP feature shows increasingly higher importance along with time, and
WBC is of stable importance. These suggest that Patient1 is suffering from worsening
inflammation or infection which both NEUP and WBC respond to, although they exhibit
different Feature Importance changing patterns. Then we find that ICAP and NP, two
kinds of ionised electrolytes in the human body, have a Feature Importance increasing
with time. Due to their medical functionality, such as hypocalcemia in AKI and adverse
outcomes [11], and dysnatremia with kidney dysfunction [33], we presume that Patient1
is developing a worsening electrolyte imbalance along with worsening infection, and thus
at high risk of progressing to AKI soon.
Then for Patient2 illustrated in Figure 15 (b), a relatively high and stable Feature Im-
portance of WBC is observed, which indicates the presence of inflammation or infection.
Besides, CO2’s (bicarbonate) Feature Importance is also on the increase, which is explained
by acidosis that builds up with progressive kidney dysfunction [16], or worsening lactic
acidosis with circulatory shock and end-organ injury including AKI [66]. Once again, the
rising Feature Importance changing pattern of NA represents progressive NA-fluid imbal-
ance and worsening kidney function in Patient2 [16, 33].
These findings suggest that the patient-level interpretation results of TRACER are valuable
and vital for doctors to identify the underlying problems of a patient so that timely
interventions can be taken for the patient.
5.3.2 Mortality Prediction in the MIMIC-III Dataset
In the in-hospital mortality prediction, we probe into two representative patients who
passed away with the Feature Importance changing patterns of five features illustrated
in Figure 16, corresponding to “Oxygen” (O2), “pH” (PH), “Carbon Dioxide” (CO2),
“Temperature” (TEMP) and “Base Excess” (BE).
Among these five, four features O2, CO2 (which in this case of the MIMIC-III dataset,
reflects pCO2 in blood gas analysis), PH and BE are medically closely related in patients’
metabolism, respiratory status, and acid-base balance. These are intimately related to
major organ functions and illness acuity. For instance, if a patient in the ICU is suf-
fering from inadequate oxygenation or ventilation, which will cause a decrease of O2 or
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Figure 16: Patient-level interpretation results of TRACER in the MIMIC-III dataset.
an increase in pCO2 respectively, the latter reflects respiratory acidosis. Concurrently,
the decreasing BE reflects worsening metabolic acidosis which in turn suggests inadequate
acid-base compensation by the deteriorating kidney function of the patient. The net result
is a lower than normal PH (acidemia). When we investigate the two patients in Figure 16,
we observe that the aforementioned four features tend to exhibit similar Feature Impor-
tance changing patterns, possibly due to their similar clinical functionalities in acid-base
balance [21].
Furthermore, TEMP is medically shown to be highly related to mortality [19, 55]. This can
be exemplified in Figure 16, in which both patients have a TEMP with a relatively large
Feature Importance value along with time.
However, when we compare Patient1 in Figure 16 (a) and Patient2 in Figure 16 (b), we can
find that Patient1’s mortality is more highly associated with derangements in oxygenation,
ventilation, and acid-base derangements; Patient2’s mortality seems more associated with
extremes of TEMP which may be the case of severe infection.
With such detailed patient-level analysis of TRACER, doctors can better understand the
possible terminal processes of a deteriorating patient and recognize the ones that are more
associated with mortality, so that priorities in therapeutic options can be identified in a
personalized manner.
5.4 Feature-Level Interpretation
In this section, we show some feature-level interpretation results in both applications to
demonstrate how TRACER functions in the feature level, e.g., helps unveil the charac-
teristics of medical features in both applications. Hence, TRACER can provide medically
meaningful insights contributing to medical research advancement. In each application, we
use the best-performing checkpoint of the TITV model in TRACER to plot the distribution
of Feature Importance - Time Window of each feature among all samples.
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Figure 17: Feature-level interpretation results of TRACER in the NUH-AKI dataset.
5.4.1 AKI Prediction in the NUH-AKI Dataset
In the NUH-AKI dataset, we illustrate the Feature Importance generated by TRACER for
six representative laboratory tests in Figure 17, corresponding to “C-Reactive Protein”
(CRP), “Neutrophils” (NEU), “Serum Potassium” (K), “Serum Sodium” (NA), “Parathy-
roid hormone, Intact” (PTH) and “RBC, Urine” (URBC). Interesting patterns from these
laboratory tests are discovered, including varying patterns (i.e., CRP, NEU, K, NA, PTH) and
a stable pattern (i.e., URBC). Our clinical collaborators have concurred that the observed
patterns are validated and proven to be medically meaningful. The detailed explanations
for the observed patterns in Figure 17 are as follows.
Similar patterns discovered in similar features. As shown in Figure 17 (a) and (b),
CRP and NEU tend to share a similar Feature Importance changing pattern along with time.
This observation is validated by doctors. According to medical literature and doctors’
domain expertise, increasing CRP suggests worsening systemic inflammatory activity in
response to various disease stressors including active infection, myocardial infarction, and
cancers [45, 59, 30], and systemic inflammation may be directly involved in pathogenesis of
AKI by altering the kidney microcirculation adversely [90, 52]. Likewise, NEU is the most
abundant type of white blood cells in human blood that responds to bacterial infection,
cancers, vascular diseases, and the former is an important mediator of inflammation [65,
74, 78]. Due to their similar medical functionality, CRP and NEU have a similar response
pattern with a sudden increase in the latter part of the time, shown in their Feature
Importance changing patterns with time.
Similarly, K and NA also exhibit similar Feature Importance - Time Window patterns
as shown in Figure 17 (c) and (d). This is because both K and NA-water balance are
important fluid and electrolytes in the human body which are vital to cellular metabolism
and regulated by the kidneys [16]. A patient would suffer derangements in K and NA
balance as kidney function deteriorates [40, 33], and these imbalances develop concurrently.
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Therefore, K and NA behave similarly in terms of Feature Importance changing patterns
with time.
Different patterns indicate different clinical functionalities. Based on the analysis
above, we can see that compared with CRP and NEU, K and NA should behave differently
in terms of Feature Importance changing pattern along with time as shown in Figure 17,
due to their different clinical functionalities.
Besides, PTH is the primary regulator of systemic calcium and phosphate homeostasis
in humans and regulates transporters to increase excretion of filtered phosphate in the
kidneys [73]. The hypocalcemia and hyperphosphatemia that develop with AKI may up-
regulate PTH activity. Skeletal resistance to PTH is also observed in kidney failure [82].
These observations explain the elevated PTH observed in patients with AKI [53, 86]. The
closer in time the measured PTH is to Prediction Window of AKI prediction, the more
significant its feature importance will be. As shown in Figure 17 (e), PTH shows a high
influence on the AKI risk, denoted as a relatively high Feature Importance which increases
in significance along with time.
Furthermore, URBC (Figure 17 (f)) exerts a relatively stable influence on the AKI risk in
terms of Feature Importance with time. The presence of URBC infers hematuria (blood in
urine). Hematuria is commonly observed in kidney (glomerular) diseases and associated
kidney dysfunction [92]. Hematuria may suggest a compromise in the glomerular filtration
barrier, and its presence has been shown to be strongly associated with kidney disease
progression over time [68]. Therefore, URBC may exhibit a stable Feature Importance on
the AKI prediction.
5.4.2 Mortality Prediction in the MIMIC-III Dataset
In the MIMIC-III dataset, we illustrate the Feature Importance changing patterns along
with time for six representative features in Figure 18, corresponding to “Serum Potassium”
(K), “Serum Sodium” (NA), “Temperature” (TEMP), “Mean Corpuscular Hemoglobin Con-
centration” (MCHC), “Cholesterol, Pleural” (CP) and “Amylase, Urine” (AU). We examine
the changing patterns and summarize our findings (which have been validated by our
clinical collaborators to be medically meaningful) with the detailed medical correlation.
Low Feature Importance detected for common features which are not generally
highly related to mortality. For K and NA as illustrated in Figure 18 (a) and (b),
they exhibit the following Feature Importance - Time Window patterns: (i) a flat curve
with low Feature Importance values with some fluctuations; (ii) a noisy area with Feature
Importance values dispersing over the whole area. We suggest that this phenomenon occurs
due to the characteristics of K and NA balance in critically ill patients. These electrolyte
disorders are very common in critically ill patients [56]; minor abnormalities may be too
general to exert significant causal effect and hence, not be highly related to mortality. This
helps explain the flat curve (i) in the figure. We note however that there are certain cases
when such common features are related to mortality; patients would have varying severity
of K and NA imbalance that persist due to the illness acuity, poor nutritional intake in
worsening disease, intravenous fluids administered in huge quantity, or loss of body fluids
in unique clinical situations with high gastrointestinal losses [33, 89]. These may lead
to various changing patterns of Feature Importance with time, which corresponds to the
noisy area (ii) in the figure.
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Figure 18: Feature-level interpretation results of TRACER in the MIMIC-III dataset.
High Feature Importance detected for common features that are generally
highly related to mortality. As shown in Figure 18 (c), TEMP has a relatively large
and stable Feature Importance with time, which means that TEMP is relatively highly
related to mortality. This observation is medically plausible. Extremes of fever and body
temperature have prognostic implications in sepsis and are among the key criteria in defin-
ing a systemic inflammatory response syndrome [18]. The alterations in TEMP could be
infection-related or a host’s response to inflammatory stress of non-infectious origin [69, 35].
High fever could predispose to cardiac arrhythmias, increased oxygen demand, seizures and
brain injury in patients and this portends adverse outcomes [62, 14]. Both hyperthermia
and hypothermia, and even pharmacological temperature lowering, are associated with
higher mortality in critically ill patients [19, 55].
Similar to TEMP, MCHC’s Feature Importance remains large with time shown in Figure 18
(d); it poses a larger influence on mortality than other appearing features. Low MCHC in-
dicates low hemoglobin concentration per red blood cell in the circulation, and may imply
lower oxygen-carrying capacity by blood cells to the tissues. This may explain the obser-
vation that lower MCHC is associated with mortality in patients with myocardial infarction
in ICU [38]. In addition, patients with sepsis and critical illness often develop acidemia or
hypophosphatemia, which in turn alters hemoglobin-oxygen affinity and reduces oxygen
release to tissues [88]. Therefore, MCHC’s effect on mortality might relate to downstream
effects on end-organ malperfusion.
Same feature’s diverging patterns indicate different patient clusters. As for CP
(Figure 18 (e)) and AU (Figure 18 (f)), we observe that their corresponding Feature Impor-
tance changing patterns with time exhibit an apparent diverging phenomenon. We suppose
such diverging patterns indicate the clinical functionality of both features in helping divide
patients into different clusters.
Specifically, CP is examined to be of supportive clinical value in differentiating two types of
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pleural effusion: exudative (higher CP) and transudative [34]. Exudative pleural effusions
either follow acute or chronic lung infection, or lung cancer; these conditions may relate
to more adverse patient outcomes and hence the association with ICU mortality. On the
other hand, low CP and transudative effusion may follow severe volume overload in the
setting of critical illness and organ injury, and there are multiple studies demonstrating
an association with fluid overload and increased ICU mortality [20, 71].
Similarly, the Feature Importance - Time Window pattern of AU is novel and interesting.
It also diverges into two types, indicating the presence of different patient clusters. AU
level is correlated to serum amylase level [85]. Serum amylase in turn is elevated in severe
clinical diseases including acute pancreatitis [42], as well as non-pancreatic abdominal
organ injury in trauma [51], and also elevated just with kidney dysfunction due to reduced
clearance [80]. In the latter, low AU may occur despite raised serum levels, which may
explain the diverging patterns illustrated in Figure 18 (f).
5.5 TRACER for Financial Analytics
We have thus far focused on evaluating TRACER in healthcare analytics. In this section,
we will move on to demonstrate how to employ TRACER in other high stakes applications
exemplified with financial analytics first, whose performance can be greatly improved with
automated financial analytic algorithms [9]. Among various financial analytics, stock index
prediction is of critical importance for the investment and trading of financial profession-
als [49].
We evaluate TRACER in the real-world stock index prediction of NASDAQ-100 Index.
Specifically, we use the NASDAQ100 dataset [75], which collects the stock prices of 81
major corporations in NASDAQ-100 and the NASDAQ-100 Index values every minute
from July 26, 2016 to December 22, 2016. This prediction is a regression task for the
current NASDAQ-100 Index with recent stock prices of the 81 constituent corporations and
the NASDAQ-100 Index values. Therefore, the index value of each minute is a prediction
target and thus corresponds to one sample [75]. In the experiment, the time window is set
to one minute and Feature Window 10 minutes.
In Figure 19, we show the feature-level interpretation results of three representative
stocks: Amazon.com, Inc. (AMZN), Lam Research Corporation (LRCX), and Viacom
Inc. (VIAB) which are a top-ranking, mid-ranking and bottom-ranking stock respectively
in NASDAQ-100 Index. Figure 19 illustrates the feature-level interpretation of all predic-
tion samples and thus, the dispersion along y-axis of each feature indicates the variability
of the corresponding feature importance in the observed time span.
We can observe in Figure 19 that Feature Importance of the three stocks is quite stable
over different time windows. This is because the prediction is made based on a 10-minute
Feature Window; therefore, the stability of stock prices is anticipated within such a short
period of time.
Further, we can notice that the three stocks exhibit different Feature Importance changing
patterns:
• AMZN [1], a top-ranking stock, has a high but fluctuating Feature Importance in the pre-
diction. The findings demonstrate that AMZN has a significant influence on NASDAQ-
100 Index, and the variance of such influence (either increase or decrease) is large, which
reveals that AMZN is an important indicator of the index.
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Figure 19: Feature-level interpretation results of TRACER in the NASDAQ100 dataset.
• LRCX [6], a mid-ranking stock, has a medium Feature Importance across time, with
moderate fluctuations among predictions. This shows that although not predominant,
such stocks are important constituents of NASDAQ-100 Index. Further, the dispersion
of Feature Importance among different samples varies mildly in different time periods,
which shows that LRCX is a valuable indicator of the index.
• VIAB, a bottom-ranking stock, shows a consistently low Feature Importance changing
pattern with minor fluctuations. The interpretation results reveal that VIAB has a small
influence on NASDAQ-100 Index. This is corroborated by a later announcement in
December, 2017 by NASDAQ that VIAB is removed from the index after re-ranking [2].
In a nutshell, the interpretation results can reveal not only the importance but also the
variability of the importance of each stock. The availability of such information is critical
in the decision making for financial professionals in investment and risk management [8]
during the management of their portfolios. The experiments confirm the capability of
TRACER in providing insights for the high stakes financial application.
5.6 TRACER for Temperature Forecasting
In this section, we demonstrate how to employ TRACER in temperature forecasting, a
critical application that targets at reducing power consumption and hence, improving
energy efficiency [93].
We evaluate TRACER in the indoor temperature forecasting application. To be specific, we
use the SML2010 dataset [93], a public dataset from UCI Machine Learning Repository [31]
which is collected from SMLsystem from March 2012 to May 2012. In this application, we
aim to predict the current indoor temperature as a regression task, given 16 time-series
sensor data sources as input features. In the experiment, the time window is set to 15
minutes and Feature Window 150 minutes.
In Figure 20, we illustrate the feature-level interpretation results of TRACER for two rep-
resentative features: sun light in south facade (SLsouth), and sun light in west facade
(SLwest), as sun light intensity is apparently one of the key influential factors to the
indoor temperature. According to the interpretation results provided by TRACER in Fig-
ure 20, we can see that SLsouth and SLwest are both important, but exhibit different
characteristics in terms of Feature Importance changing patterns.
• SLsouth’s rising Feature Importance across time. We note that this SML2010 dataset
is collected from March to May at CEU-UCH in Valencia, Spain [93], i.e., during the
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Figure 20: Feature-level interpretation results of TRACER in the SML2010 dataset.
spring in the mid-latitude region where the temperature differs much between day and
night, and the sun shines on the south facade mostly in the daytime, yet shines on the
west facade in the evening. Therefore, SLsouth can represent the real-time sun light
intensity. The nearer to prediction in time, the larger influence SLsouth can pose to the
indoor temperature. This agrees with the rising Feature Importance of SLsouth along
with time calculated by TRACER.
• SLwest’s stable Feature Importance over time. Different from the south facade, the sun
shines on the west facade only in the evening when it is relatively dark. This causes
SLwest to serve as a relatively stable indicator of outdoor darkness (e.g., daytime vs.
night, sunny vs. cloudy). Hence, SLwest exhibits a relatively stable Feature Importance
over time, with a slight decrease approaching the prediction time. This decrease appears
due to the fact that in the time windows near prediction, other features that can rep-
resent the real-time sun light intensity such as SLsouth are relatively more important.
These findings are well reflected by the interpretation results from TRACER.
Based on the experimental results and analysis above, TRACER is shown to help unveil the
characteristics of features in this indoor temperature forecasting application and hence,
provide meaningful information to the corresponding domain practitioners. As a result, we
confirm the applicability of TRACER in this critical temperature forecasting application.
6 Conclusions
Interpretability has been recognized to play an essential role in designing analytic mod-
els in high stakes applications such as healthcare analytics. Feature importance is one
common way to interpret the predictions of analytic models. In this paper, we propose to
capture the feature importance in two aspects: the time-invariant and the time-variant fea-
ture importance, respectively reflecting the overall influence of the feature shared across
time and the time-related influence which may vary along with time. We devise TITV
to model the time-invariant feature importance via feature-wise transformation, and the
time-variant feature importance via self-attention. With TITV as the core component, we
propose a framework TRACER to provide accurate and interpretable clinical decision sup-
port to doctors and insightful advice to practitioners of other high stakes applications as
well. We first evaluate the effectiveness of TRACER in healthcare analytics by conducting
extensive experiments over the NUH-AKI dataset and the MIMIC-III dataset for AKI pre-
diction and mortality prediction. The results show that TRACER is able to provide more
accurate predictions than all the baselines in both datasets. Further, the interpretation
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results have also been validated to be medically meaningful by the clinicians. We also
evaluate TRACER in a financial application and a temperature forecasting application to
demonstrate its applicability in other high stakes applications.
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